St. Petersburg, Florida-based Jabil and Maple Grove, Minnesota-based MIS said the deal will allow them to “offer enhanced catheter design and development capabilities to medical device OEMs, leveraging Jabil’s global manufacturing footprint and supply chain scale.”
MIS provides design and development services, testing, extrusion, reflow, coiling, braiding, balloon forming, laser welding and finished goods assembly.
Jabil has more than 100 global facilities serving customers in the automotive, consumer electronics, medtech and pharma industries. It’s medical device business includes orthopedics, surgical tools, robotics, in-vitro diagnostics, chronic disease management platforms like insulin pumps, and autoinjectors for GLP-1 drugs.
The Jabil and MIS collaboration creates “a powerful combination of expertise and resources across the medical device lifecycle to create a one-stop-shop for complex catheter solutions,” Jabil Healthcare VP of Medical Technology Shane Smith said in a news release. “Healthcare OEMs can take advantage of MIS’s rapid prototyping, iterative testing, and optimized catheter design, which is then transferred for assembly at scale across Jabil’s global network of healthcare sites throughout the Americas, Europe, and Asia.”
MIS CEO Bryan Patrick said the partnership with Jabil “enables us to scale our expertise in advanced minimally invasive devices to a broader range of life-saving products. In addition, we now have unparalleled access to geographically diverse, low-cost, manufacturing services that will allow us to maintain our world-class standards of customer service and device quality to an even wider group of customers.”
Related: What is minimally invasive medtech? It depends on who you ask.
